Saudi Central Bank Buys 21,120 Shares of Danaher Corporation $DHR

Saudi Central Bank lifted its stake in shares of Danaher Corporation (NYSE:DHRFree Report) by 90.0% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 44,585 shares of the conglomerate’s stock after acquiring an additional 21,120 shares during the period. Saudi Central Bank’s holdings in Danaher were worth $8,493,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of DHR. Main Street Group LTD bought a new stake in Danaher in the first quarter valued at $25,000. N.E.W. Advisory Services LLC bought a new position in shares of Danaher during the 2nd quarter worth about $25,000. JPL Wealth Management LLC bought a new position in shares of Danaher during the 3rd quarter worth about $25,000. WFA of San Diego LLC acquired a new stake in shares of Danaher in the 2nd quarter valued at about $26,000. Finally, Hilton Head Capital Partners LLC bought a new stake in Danaher in the 4th quarter valued at about $27,000. 79.05% of the stock is owned by institutional investors.

Danaher Trading Down 1.7%

NYSE DHR opened at $207.46 on Friday. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48. The business has a fifty day simple moving average of $201.74 and a 200 day simple moving average of $192.28. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80. The firm has a market capitalization of $145.84 billion, a P/E ratio of 36.85, a PEG ratio of 2.59 and a beta of 0.78.

Danaher (NYSE:DHRGet Free Report) last posted its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.85 by $0.09. The firm had revenue of $6.26 billion for the quarter, compared to the consensus estimate of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The business’s revenue for the quarter was up 5.5% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.77 EPS. On average, analysts predict that Danaher Corporation will post 8.53 EPS for the current fiscal year.

Analyst Ratings Changes

A number of research analysts recently weighed in on the company. Citigroup assumed coverage on Danaher in a research note on Tuesday, May 26th. They set a “buy” rating and a $230.00 price target on the stock. Wells Fargo & Company decreased their price objective on Danaher from $212.00 to $195.00 and set an “equal weight” rating for the company in a report on Wednesday, July 22nd. Wolfe Research cut Danaher from an “outperform” rating to a “peer perform” rating in a report on Monday, June 1st. HSBC lowered their price objective on shares of Danaher from $270.00 to $230.00 and set a “buy” rating on the stock in a report on Wednesday, June 3rd. Finally, Piper Sandler initiated coverage on shares of Danaher in a research report on Thursday, June 11th. They set a “neutral” rating and a $200.00 target price for the company. One analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat, Danaher currently has a consensus rating of “Moderate Buy” and a consensus price target of $228.91.

View Our Latest Report on Danaher

About Danaher

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Read More

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.